CINCINNATI, June 1, 2018 /PRNewswire/ -- June 1, 2018 marks the 15th anniversary for Camargo Pharmaceutical Services, LLC, ("Camargo"). Camargo has grown from a small strategic drug development services provider to become the global leader in 505(b)(2) drug development and global equivalents with multiple locations serving customers all over the world. To celebrate, Camargo invited employees and their families, friends, and special guests to the company's headquarters for an Open House Reception.
Since the beginning, Camargo has been instrumental in helping global pharmaceutical companies identify, develop, and obtain numerous 505(b)(2) NDA approvals. The company was founded in Cincinnati in 2003 by Ken Phelps (President and Founder) and Dr. Ruth Stevens (Chief Scientific Officer and Founder) and focused on being pharmaceutical industry's 505(b)(2) development partner of choice. "For the last 15 years, we have dedicated ourselves to providing strategic drug development services with the highest quality to global pharmaceutical companies around the world…and we look forward to an even brighter future," said Phelps.
Camargo improves medicines by leveraging existing drugs and, more recently, has been involved in one of every five 505(b)(2) NDA approvals. Of the many accomplishments achieved over the course of its 15-year history, Camargo is extremely proud of making a difference in people's lives every day. "We have a wonderful family at Camargo and we are extremely passionate about the work we do. Improving medicines benefits countless lives all over the world," said Stevens. Camargo has the most experienced team of experts providing comprehensive drug development services specialized for the 505(b)(2) approval pathway and global equivalent processes.
"Camargo has achieved this milestone through the hard work and dedication of our employees and our culture of excellence. With their continual support and with the foundation built in the past, I have great confidence that Camargo will continue to excel well into the future," said Dan Duffy, Chief Executive Officer.
ABOUT CAMARGO PHARMACEUTICAL SERVICES, LLC.
Camargo Pharmaceutical Services, LLC, headquartered in Cincinnati, OH, was founded in 2003 by Kenneth V. Phelps (President and Founder) and Dr. Ruth Stevens (Chief Scientific Officer and Founder). Camargo provides comprehensive drug development services and specializes in the 505(b)(2) approval pathway and global equivalent processes. By assessing the scientific, medical, regulatory, and commercial viability of product development opportunities, Camargo builds and executes robust development plans that align with business strategies and ensures regulatory agency buy-in every step of the way. Routinely holding three to six meetings a month with the Food and Drug Administration (FDA), Camargo works with product developers across more than 25 countries. For more about Camargo, visit http://camargopharma.com.